Biosimilar Market in Europe Size, Share, Forecast 2027 | Segmentation, Report and Industry Analysis

According to the latest report by IMARC Group, titled "Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the biosimilar market in Europe reached a value of US$ 6,735 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 25,446 Million by 2027, exhibiting at a CAGR of 22.8% during 2022-2027.

Biosimilars are biotherapeutic products that are identical copies of original prescription medicine manufactured by a different company. The drug is produced using living organisms and cells that have complex molecular structures and are manufactured after the patent of the reference product expires. The manufacturer then seeks approval from regulatory authorities to produce biosimilar product versions. Biosimilars are cheaper than their original counterparts and similar in efficacy, safety, and quality. In Europe, the biosimilars market is largely driven by rapid technological advancements and is expected to have an equal footing with standard-of-care (SOC) drugs.  

Request for a PDF Sample of this Report: https://www.imarcgroup.com/europe-biosimilar-market/requestsample

Europe Biosimilar Market Trends:

The biosimilar market in Europe is primarily driven by the increasing geriatric population and the rising prevalence of chronic conditions such as cardiovascular diseases (CVDs), diabetes, and pulmonary diseases. Additionally, regional governments are actively working to incentivize physicians, pharmacists, and patients in favor of biosimilars over branded biologics, which, in turn, is creating a positive outlook for the market. Moreover, the burgeoning healthcare expenditure and the rising patient awareness regarding biosimilars are providing a considerable boost to the market growth. Other factors, such as  surging investments by private and public organizations to upgrade the existing healthcare infrastructure, increasing research and development (R&D) activities, and rapid patent expiration of blockbuster biologics, are positively contributing to the market growth.

Europe Biosimilar Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the biosimilar market in Europe has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these Key Players Include:

  • Novartis
  • Pfizer
  • Teva
  • Celltrion
  • Samsung Bioepis
  • Amgen
  • Apotex
  • Ratiopharm
  • Mylan
  • Merck Sharp & Dohme
  • Eli Lilly
  • Accord Healthcare Ltd
  • Boehringer Ingelheim
  • Hexal Ag
  • Stada Arzneimittel Ag

Key Market Segmentation:

Breakup by Country:

  • Italy
  • Germany
  • United Kingdom
  • France
  • Spain
  • Rest of Europe

Breakup by Molecule:

  • Infliximab
  • Insulin Glargine
  • Epoetin Alfa
  • Etanercept
  • Filgrastim
  • Somatropin
  • Rituximab
  • Follitropin Alfa
  • Adalimumab

Breakup by Indication:

  • Auto-Immune Diseases
  • Blood Disorder
  • Diabetes
  • Oncology
  • Growth Deficiency
  • Female Infertility

Breakup by Manufacturing Type:

  • In-house Manufacturing
  • Contract Manufacturing

Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=1023&flag=E

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter's Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:                                                                     

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us:

IMARC Group

30 N Gould St, Ste R

Sheridan, WY 82801, USA

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

 

Popular posts from this blog

Europe Beer Market Share, Size, Forecast & Analysis 2023-2028

Image
IMARC Group, a leading market research company, has recently releases report titled “Europe Beer Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the   Europe beer market share , size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. How Big is the Europe Beer Market? The Europe beer market size reached US$ 146.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 167.7 Billion by 2028, exhibiting a growth rate (CAGR) of 2.4% during 2023-2028. Request to Get the Sample Report: https://www.imarcgroup.com/europe-beer-market/requestsample Factors Affecting the Growth of the Europe Beer Industry:     Shifting Consumer Preferences: The beer market in Europe is experiencing notable growth as consumer preferences undergo continuous evolution. In addition to this, ther...
Read more

GCC LED Lighting Market Size, Trends, Growth, Forecast & Industry Report 2024-2032

Image
According to IMARC Group, the GCC led lighting market share reached us$ 876.9 million in 2023 . Looking forward, Imarc group expects the market to reach us$ 2,174.9 million by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032. The report has segmented the market by product type (panel lights, down lights, street lights, and others), application (residential, commercial, industrial, and others), import and domestic manufacturing (imports, domestic manufacturing), public and private sectors (public sector, private sector), outdoor and indoor application (indoor, outdoor), and region. Request to Get the Sample Report: https://www.imarcgroup.com/gcc-led-lighting-market/requestsample What is the LED Lighting Market ? Light Emitting Diode (LED) lighting has emerged as a transformative technology in the field of illumination, revolutionizing the lighting solutions are perceived and utilized. LEDs are semiconductor devices that emit light when an electrical current passes...
Read more

Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Unit Setup and Machinery

Image
IMARC Group’s report, titled “ Bulletproof Glass Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue ” provides a complete roadmap for setting up a  bulletproof glass manufacturing plant . The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the operational aspects, the report also provides in-depth insights into bulletproof glass manufacturing process, project economics, encompassing vital aspects such as capital investments, project funding, operating expenses, income and expenditure projections, fixed and variable costs, direct and indirect expenses, expected ROI, net present value (NPV), profit and loss account, and thorough financial analysis, amon...
Read more